The human wild-type (R482) ABCG2-transfected cells were used for rational screening of inhibitory acridones.
A novel pyridothiophene inhibitor of PTP1B was discovered by rational screening of phosphotyrosine mimics at high micromolar concentrations.
The idea behind EMICs is clear and straightforward, but the huge pool of variables in its synthesis and characterization requires some rational screening strategies.
The current work implied that rational screening of transient pore-forming polymer in solid dispersion could be a robust approach for controlling hydrophilic drug release.
The aim of this work was to regulate the dissolution of hydrophilic drug from hot-melt extruded solid dispersion via rational screening of the pore-forming agents.
Atom-resolution and time-resolved insights are provided to microscopically and fundamentally elucidate cellulose dissolution/regeneration, which are indispensable in the rational screening and design of new ILs for efficient cellulose pretreatment.
Our integrin specific ligand functionalized 3D organoids mimic a lymphoid neoplasm-like heterogeneous microenvironment that could, in the long term, change the understanding of the initiation and progression of hematological tumors, allow primary biospecimen analysis, provide prognostic values, and importantly, allow a faster and more rational screening and translation of therapeutic regimens.
The primary aim was to determine the prevalence of different levels of albuminuria, some (cardiovascular) risk factors and their associations, to develop a rational screening strategy for albuminuria in the healthy population.
Previously, we reported that the rational screening of representatives of different types of compound library from Specs (www.specs.net) led to identification of a two-mode acting ABCG2 inhibitor PZ-39 [7].
Using rational screening of representatives from a chemical compound library, we found a novel inhibitor of ABCG2, PZ-39 (N- 4-chlorophenyl -2-[ 6-{[4,6-di 4-morpholinyl -1,3,5-triazin-2-yl]amino}-1,3-benzothiazol-2-yl)sulfaN- 4-chlorophenyl -2-[ 6-{[4,6-di 4-morpholinyl -1,3,5-triazin-2-yl]amino}-1,3-benzothiazol-2-ylts lysosome-depeN- 4-chlorophenyl -2-[ 6-{[4,6-di 4-morpholinyl -1,3,5-triazin-2-yl]amino}-1,3-benzothiazol-2-yl
In this sense, chemogenomics provides a complementary strategy for a rational screening that includes structural information of chemical compounds for gene targets [ 2, 3].
